Brief: AnGes MG to grant development manufacturing and marketing rights to Morishita Jintan
16/06/2016 02:33
June 16 (Reuters) - AnGes MG Inc 4563.T :
* Says it reached basic agreement with Morishita Jintan Co
Ltd 4524.T on June 16
* Says it to grant exclusive development, manufacturing and
marketing rights of cervical pre-cancer therapeutic vaccine to
Morishita Jintan
Source text in Japanese: https://goo.gl/NAeCci
Further company Coverage: 4563.T 4524.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: qiujing.li.thomsonreuters.com@reuters.net))